Neither company is particularly attractive at current prices.

CLASSIFICATION: SYNTHETIC PEPTIDE (REPAIR & RECOVERY) ACTIVE SUBSTANCE: THYMOSIN BETA-4 FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: 2.5-3 DAYS DOSAGE: MEN 7.66 MG/WEEK ACNE: NO WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: NOOTROPIC PEPTIDE ACTIVE SUBSTANCE: SELANK FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 2-3 HOURS DOSAGE: MEN 250-500 MCG/DAY ACNE: NO WATER RETENTION: MINIMAL HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: SYNTHETIC MELANOCORTIN PEPTIDE ACTIVE SUBSTANCE: MELANOTAN 2 FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 3036 HOURS DOSAGE: 0.251 MG/DAY (LOADING), THEN 0.51 MG EVERY 23 DAYS (MAINTENANCE) ACNE: NO WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: NOOTROPIC PEPTIDE ACTIVE SUBSTANCE: SEMAX FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: 2-3 HOURS DOSAGE: MEN 200-600 MCG/DAY ACNE: NO WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: BODY PROTECTING COMPOUND ACTIVE SUBSTANCE: PENTADECAPEPTIDE FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 4-6 HOURS DOSAGE: 200-500 MCG/DAY ACNE: NOT REPORTED WATER RETENTION: NONE HIGH BLOOD PRESSURE (HBP): NO KNOWN IMPACT HEPATOTOXICITY: NONE AROMATIZATION: DOES NOT AROMATIZE MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: PEPTIDE BLEND/HEALING & RECOVERY ACTIVE SUBSTANCES: - 5 MG THYMOSIN BETA 4 - 5 MG PENTADECAPEPTIDE FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: TB 500: 2-3 DAYS

Harsh skincare products
Examples of mismatches that lead to disappointment Hip pain that is actually lumbar referral or gluteal tendinopathy aggravated by gait mechanics Shoulder pain driven by scapular dyskinesis, thoracic stiffness, or cervical contribution Elbow tendonitis that is nerve irritation or grip overload rather than tendon degeneration Knee pain driven by patellofemoral tracking, ankle mobility restriction, or quad dominance In those situations, using BPC-157 or TB-500 alone can feel like an expensive detour
The goal is always the lowest effective dose that delivers meaningful outcomes
About eight in ten (79%) adults who have taken GLP-1 drugs report getting these drugs or a prescription for them from their primary care doctor or a specialist, while fewer report getting them from an online provider or website (11%), a medical spa or aesthetic medical center (10%), or from somewhere else (2%)